Benzinga | Nov 9, 2020 07:15AM EST

Recap: Genesis Healthcare Q3 Earnings



Shares of Genesis Healthcare (NYSE:GEN) moved higher by 4.3% in pre-market trading after the company reported Q3 results.

Quarterly Results

Earnings per share were down 311.54% over the past year to ($0.55), which missed the estimate of ($0.36).

Revenue of $938,653,000 decreased by 16.49% year over year, which missed the estimate of $993,970,000.

Looking Ahead

Genesis Healthcare hasn't issued any earnings guidance for the time being.

Genesis Healthcare hasn't issued any revenue guidance for the time being.

Recent Stock Performance

52-week high: $1.86

Company's 52-week low was at $0.40

Price action over last quarter: down 34.56%

Company Overview

Genesis Healthcare Inc is a post-acute care provider in the United States. It focuses on the medical and physical issues facing elderly patients and is provided by the employees of skilled nursing facilities, assisted/senior living communities, integrated and third-party rehabilitation therapy business. The company has three operating segments. The inpatient services segment include the operation of skilled nursing facilities and assisted/senior living facilities; rehabilitation therapy segment services include integrated and third-party rehabilitation and respiratory therapy services; and all other services. The majority of its revenue is generated from its skilled nursing facilities of the inpatient services segment.